Subfulminant hepatic failure in autoimmune hepatitis type 1: An unusual form of presentation

Journal of Hepatology

Volumn 27, Issue 3, 1997, Pages 578-582

  Herzog, Denise ^b   Rasquin Weber, Andrée Marie ^b   Debray, Dominique ^a   Alvarez, Fernando ^b  

^a BICÊTRE HOSPITAL   (France)

^b NONE

Author keywords

Autoimmune hepatitis type 1; Female adolescent; Subfulminant hepatic failure

Indexed keywords

ADOLESCENT; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNE HEPATITIS; CASE REPORT; FEMALE; GENETIC PREDISPOSITION; HUMAN; HYPERGAMMAGLOBULINEMIA; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LIVER CIRRHOSIS; LIVER FAILURE; PRIORITY JOURNAL; PUBERTY; SPLENOMEGALY;

EID: 0030845841     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80364-9     Document Type: Article

References (38)

1. Poupon R, Petit J, Bodin F, De Saint-Maur PP, Homberg JC, Darnis F. Hépatites chroniques: intéret d'une classification fondée sur la présence ou l'absence de l'antigène HBs, de l'anticorps anti-muscle lisse et de l'anticorps antiréticulum endoplasmique. Gastroenterol Clin Biol. 4:1980;666-673.
2. Maggiore G, Veber F, Bernard O, Hadchouel M, Homberg JC, Alvarez F, et al. Autoimmune hepatitis associated with anti-actin antibodies in children and adolescents. J Pediatr Gastroenterol Nutr. 17:1993;376-381.
3. Homberg JC, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil S, et al. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of autoimmune hepatitis. Hepatology. 7:1987;1333-1339.
4. Manns M, Gerken K, Kyriatsolis A, Staritz M, Meyer zum Büschenfelde KH. Characterization of a new subgroup of autoimmune chronic hepatitis by antibodies against soluble liver antigen. Lancet. 1:1987;292-294.
5. Odièvre M, Maggiore G, Homberg JC, Saadoun F, Couroucé AM, Yvart J, et al. Seroimmunologic classification of chronic hepatitis in 57 children. Hepatology. 3:1983;407-409.
6. Maggiore G, Bernard O, Hadchouel M, Hadchouel P, Odievre M, Alagille D. Treatment of autoimmune chronic active hepatitis in childhood. J Pediatr. 104:1984;839-844.
7. Maggiore G, Alvarez F, Bernard O, Sokal EM. Autoimmune chronic hepatitis. Buts JP. 1st ed. Management of Digestive and Liver Disease in Infants and Children. 1993;567-574 Elsevier Science Publishers B.V. Amsterdam.
8. Sheron N, Eddleston A. Autoimmune chronic active hepatitis. McIntyre N, Benhamou JP, Bircher J, Rizzetto M, Rodes J. 1st ed Oxford Textbook of Hepatology. 2:1991;758-767 Oxford University Press, Oxford.
9. Whittingham S, Mathews JD, Schonfield MS, Talt BD, Machay IR. Interaction of HLA and Gm in autoimmune chronic active hepatitis. Clin Exp Immunol. 43:1981;80-86.
10. Czaja AJ, Rakela J, Ludwig J. Features reflective of early prognosis in corticoid treated severe autoimmune chronic active hepatitis. Gastroenterology. 95:1988;448-453.
11. Nikias GA, Batts KP, Czaja AJ. The nature and prognostic implication of autoimmune hepatitis with an acute presentation. J Hepatol. 21:1994;866-871.
12. Hyams JS, Ballow M, Leichtner AM. Cyclosporine treatment of autoimmune chronic active hepatitis. Gastroenterology. 93:1987;890-893.
13. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis. 6:1986;97-106.
14. Maggiore G, Porta G, Bernard O, Hadchouel M, Alvarez F, Homberg JC, et al. Autoimmune hepatitis with initial presentation as acute hepatic failure in young children. J Pediatr. 116:1990;280-282.
15. Porta G, Da Costa-Grayotto LC, Alvarez F. Anti-liver kidney microsome antibodies positive autoimmune heepatitis, presenting as fulminant liver failure. J Pediatr Gastroenterol Nutr. 11:1990;138-140.
16. Gregorio GV, Portmann B, Vergani D, Mowat AP, Mieli-Vergani G. Autoimmune hepatitis in childhood: a 20 year review. Hepatology. 18:1993;175A.
17. Maggiore G, Bernard O, Hadchouel M, Alagille D. Life-saving immunosuppressive treatment in severe autoimmune chronic active hepatitis. J Pediatr Gastroenterol Nutr. 4:1985;655-658.
18. J Neuberger, Portmann B, Calne R, Williams R. Recurrence of autoimmune chronic active hepatitis following orthoptic liver grafting. Transplantation. 37:1984;363-365.
19. Manns M, Meyer zum Büschenfelde KH, Slurasczyk J. Detection of liver-kidney microsomal antibodies and their relation to antimitochondrial antibodies in inflammatory liver disease. Clin Exp Immunol. 57:1984;600-608.
20. Tan KL, Mondragon RS, Vougas V, Mieli-Vergani G, Heaton ND, Mowat AP, et al. Liver transplantation for fulminant hepatic failure and late onset hepatic failure in children. Br J Surg. 79:1992;1192-1194.
21. Brun JM. Juvenile autoimmune polyendocrinopathy. Hormone Res. 16:1982;308-316.
22. Manns M, Krüger M. Immunogenetics of chronic liver disease. Gastroenterology. 106:1994;1676-1697.
23. Sokol RJ. Fulminant hepatic failure. Balistrieri WF, Stocker JT. Pediatric Hepatology. 1990;315-362 Hemisphere Publishing, New York.
24. Jones EA, Schafer DF, Zakim D, Boyer TD. Fulminant hepatic failure. 2nd ed Hepatology. 1990;466-492 WB Saunders, Philadelphia.
25. Whitington PF. Fulminant hepatic failure in children. Suchy FJ. 1st ed. Liver Disease in Children. 1994;180-213 Mosby Year Book, St. Louis.
26. O'Grady J, Williams R. Acute liver failure. Baillères Clin Gastroenterol. 30:1989;75-89.
27. Sheiner PA, Bodebheimer H, Klion F. Predictors of outcome of acute autoimmune hepatitis. Hepatology. 20:1994;398A.
28. Scully LJ, Tozc C, DPE Sengas, Goldstein R. Early onset autoimmune hepatitis is associated with C4A gene deletion. Gastroenterology. 104:1993;1478-1484.
29. Czaja AJ, Rakela J, Hay JE, Moore SB. Clinical and prognostic implications of HLA B8 in corticoid treated severe autoimmune chronic active hepatitis. Gastroenterology. 98:1990;1587-1593.
30. Doherty DG, Underhill JA, Donaldson PT, Manabe K, Mieli-Vergani G, Eddlestone AL, et al. Polymorphism in the human complement C4 genes and genetic susceptibility to autoimmune hepatitis. Autoimmunity. 18:1994;243-249.
31. Vergani D, Wells L, Larcher VF, Nasaruddin BA, Davis CT, Mieli-Vergani G, et al. Genetically determined low C4: a predisposing factor to autoimmune chronic active hepatitis. Lancet. ii:1985;294-298.
32. Oerter-Klein K, Baron J, Colli MJ, McDonnell DP, Cutler GB Jr. Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay. J Clin Invest. 94:1994;2475-2480.
33. Venturoli S, Porcu E, Fabbri R, Magrini O, Gammi L, Paradisi R, et al. Longitudinal evaluation of different gonadotropin pulsatile patterns in anovulatory cycles of young girls. J Clin Endocrinol Metabol. 74:1992;836-841.
34. Venturoli S, Porcu E, Fabbri R, Magrini O, Paradisi R, Pallotti G, et al. Postmenarchal evolution of endocrine pattern and ovarian aspects in adolescents with menstrual irregularities. Fertil Steril. 48:1987;78-85.
35. Marshall JC. Hormonal regulation of the menstrual cycle and the mechanisms of anovulation. De Groot LJ. 3rd ed. Endocrinology. 3:1995;2052 Saunders, New York.
36. Cohen JHM, Danel L, Cordier G, Saez S, Revillard JP. Sex steroid receptors in peripheral T-cells: absence of androgen and restriction of estrogen receptors to OKT 8 positive cells. J Immunol. 131:1983;2767-2772.
37. Paavonen T, Andersson LC, Adlercreutz H. Sex hormone regulation of in vitro immune response. Estradiol enhances human B-cell maturation via inhibition of suppressor T-cells in pokeweed stimulated cultures. J Exp Med. 154:1981;1935-1941.
38. Ahmed AS, Dauphinée MJ, Talal N. Effects of short-term administration of sex hormones in normal and autoimmune mice. J Immunol. 134:1985;204-210.